The use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.
The use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.
复制标题
使用(18)F-2-氟脱氧葡萄糖(FDG)将胰腺癌免疫细胞的抗体片段标记。
DOI:
10.1021/acscentsci.5b00121
复制
发表时间:
2015-06-24
影响因子:
18.2
通讯作者:
Ploegh H
中科院分区:
文献类型:
--
作者:
Rashidian M;Keliher E;Dougan M;Juras PK;Cavallari M;Wojtkiewicz GR;Jacobsen J;Edens JG;Tas JM;Victora G;Weissleder R;Ploegh H
We generated 18F-labeled antibody fragments for positron emission tomography (PET) imaging using a sortase-mediated reaction to install a trans-cyclooctene-functionalized short peptide onto proteins of interest, followed by reaction with a tetrazine-labeled-18F-2-deoxyfluoroglucose (FDG). The method is rapid, robust, and site-specific (radiochemical yields > 25%, not decay corrected). The availability of 18F-2-deoxyfluoroglucose avoids the need for more complicated chemistries used to generate carbon–fluorine bonds. We demonstrate the utility of the method by detecting heterotopic pancreatic tumors in mice by PET, using anti-Class II MHC single domain antibodies. We correlate macroscopic PET images with microscopic two-photon visualization of the tumor. Our approach provides easy access to 18F-labeled antibodies and their fragments at a level of molecular specificity that complements conventional 18F-FDG imaging. 18F-2-Deoxyfluoroglucose combined with sortase is used to site-specifically label antibody fragments. A new mouse Class II MHC specific 18F-labeled VHH not only decorated lymphoid organs but also detected a heterotopic pancreatic tumor (∼1.5 mm) due to the presence of immune cells. 1, 2, 3: lymph nodes, 4: thymus, 5: tumor.